A comprehensive programme to strengthen adherence to antiretroviral drug therapy and achieve virological control in HIV infected children in Thailand

Vulnerable Children and Youth Studies

Volumn 1, Issue 2, 2006, Pages 180-191

  Hansudewechakul, Rawiwan ^a   Jourdain, Gonzague ^b   Plangraun, Numphung ^c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c ACCESS Foundation   (Thailand)

Author keywords

Adherence; Anti retroviral drugs; Children; Cohort; Daycare; Developing country; Fixed dose combination; Globle Fund; Malaria; Nevirapine; Thailand; Tuberculosis; Viral load

Indexed keywords

EID: 84967078806     PISSN: 17450128     EISSN: 17450136     Source Type: Journal    
DOI: 10.1080/17450120600810241     Document Type: Article

References (28)

1. Brugha, R., and Walt, G., 2001. A global health fund:A leap of faith?. British Medical Journal, 323:152–154.
2. Chavalittamrong, B., and Tantiwongse, P., 1987. Height and weight of Thai children:Update. Journal of the Medical Association of Thailand, 70 (Suppl. 1):1–40.
3. Centers for Disease Control (CDC). 1994. Revised classification system for HIV-1 infection in children less than 13 years of age. Morbidity and Mortality Weekly Report, 43:1–10.
4. Crespo-Fierro, M., 1997. Compliance/adherence and care management in HIV disease. Journal of the Association of Nurses in AIDS Care, 8:43–54.
5. Farley, J., Hines, S., Musk, A., Ferrus, S., and Tepper, V., 2003. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. Journal of Acquired Immune Deficiency Syndrome, 33:211–218.
6. Funck-Brentano, I., Dalban, C., Veber, F., 2005. Evaluation of a peer support group therapy for HIV-infected adolescents. AIDS, 19:1501–1508.
7. Gibb, D. M., Goodall, R. L., Giacomet, V., McGee, L., Compagnucci, A., and Lyall, H., 2003. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatric Infectious Disease Journal, 22:56–62.
8. Goujard, C., Bernard, N., Sohier, N., 2003. Impact of a patient education program on adherence to HIV medication:a randomized clinical trial. Journal of Acquired Immune Deficiency Syndrome, 34:191–194.
9. Hansudewechakul, R., Plangraun, N., and Yodsuwan. How to achieve >95% adherence for children on antiretroviral therapy (ART) in a resource limited country. XV International AIDS Conference. July11–16, Bangkok. Paper presented at the
10. Harries, A. D., Nyangulu, D. S., Hargreaves, N. J., Kaluwa, O., and Salaniponi, F. M., 2001. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet, 358:410–414.
11. Kanshana, S., and Simonds, R. J., 2002. National program for preventing mother–child HIV transmission in Thailand:successful implementation and lessons learned. AIDS, 16:953–959.
12. Le Coeur, S., Jourdain, G., Collins, I., Ngo-Giang-Huong, N., and Lallemant, M., 2004. “ Prevention of mother-to-child transmission of HIV in Thailand:Striding towards access to HAART for the family ”. In AIDS in Asia, Edited by:Lu, Y., and Essex, M., 457–469. NewYork:K. A.-P. Publishers.
13. Marhefka, S. L., Farley, J. J., Rodrigue, J. R., Sandrik, L. L., Sleasman, J. W., and Tepper, V. J., 2004. Clinical assessment of medication adherence among HIV-infected children:Examination of the Treatment Interview Protocol (TIP). AIDS Care, 16:323–338.
14. Mellins, C. A., Brackis-Cott, E., Dolezal, C., and Abrams, E. J., 2004. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatric Infectious Disease Journal, 23:1035–1041.
15. Ministry of Public Health (MOPH). 2003. Guidelines for the management of prevention of mother to child transmission of HIV in Thailand, Thailand:Ministry of Public Health.
16. Ministry of Public Health. 2004. Surveillance systems on HIV/AIDS in Thailand
17. Murphy, D. A., Wilson, C. M., Durako, S. J., Muenz, L. R., and Belzer, M., 2001. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care, 13:27–40.
18. Paterson, D. L., Swindells, S., Mohr, J., 2000. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133:21–30.
19. Popp, D., and Fisher, J. D., 2002. First, do no harm:A call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world. Aids, 16:676–678.
20. Puthanakit, T., Oberdorfer, A., Akarathum, N., 2005. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand' National Access to Antiretroviral Program. Clinical Infectious Diseases, 41:100–107.
21. Roter, D. L., Hall, J. A., Merisca, R., Nordstrom, B., Cretin, D., and Svarstad, B., 1998. Effectiveness of interventions to improve patient compliance:a meta-analysis. Medical Care, 36:1138–1161.
22. Safren, S. A., Otto, M. W., Worth, J. L., 2001. Two strategies to increase adherence to HIV antiretroviral medication:life-steps and medication monitoring. Behaviour Research and Therapy, 39:1151–1162.
23. Schackman, B. R., Finkelstein, R., Neukermans, C. P., Lewis, L., and Eldred, L., 2005. The cost of HIV medication adherence support interventions:Results of a cross-site evaluation. AIDS Care, 17:927–937.
24. Stenzel, M. S., McKenzie, M., Mitty, J. A., and Flanigan, T. P., 2001. Enhancing adherence to HAART:A pilot program of modified directly observed therapy. AIDS Reader, 11:317–319. 324–318
25. van Leth, F., Andrews, S., Grinsztejn, B., 2005. The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. AIDS, 19:463–471.
26. Verweel, G., Sharland, M., Lyall, H., 2003. Nevirapine use in HIV-1-infected children. AIDS, 17:1639–1647.
27. World Health Organization (WHO). 2003. “ Scaling up antiretroviral therapy in resource-limited settings:Treatment guidelines for a public health approach ”. 67Geneva:World Health Organization.
28. Workman, C., 1999. The process of supporting adherence. Focus, 14:1–4.